LeMaitre Vascular, Inc. (FRA:LHU)

Market Cap	1.72B -1.8%
Revenue (ttm)	229.71M +11.8%
Net Income	57.48M +39.4%
EPS	2.55 +39.4%
Shares Out	n/a
PE Ratio	29.60
Forward PE	27.13
Dividend	0.82 (1.09%)
Ex-Dividend Date	Aug 20, 2026

Volume	400
Open	75.50
Previous Close	73.50
Day's Range	75.50 - 75.50
52-Week Range	66.00 - 99.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheter...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1983
• Employees: 651
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LHU

Financial Performance

In 2025, LeMaitre Vascular's revenue was $249.60 million, an increase of 13.53% compared to the previous year's $219.86 million. Earnings were $57.73 million, an increase of 31.10%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error